Trial Profile
Oral Contraceptives in the Metabolic Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/norgestimate (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- 07 Jun 2018 Status changed from active, no longer recruiting to completed.
- 12 Mar 2018 Planned End Date changed from 1 Dec 2017 to 1 Apr 2018.
- 23 Mar 2017 Planned End Date changed from 1 Jun 2014 to 1 Dec 2017.